Welcome to GENESIS Hangzhou!

  • COVID-19: Antibody Limits Under Discussion

    COVID-19: Antibody Limits Under Discussion

    COVID-19: Antibody Limits Under Discussion   How high do antibody titres have to be in order to be protected from COVID-19 infection after a corona vaccination? This question is still currently subject of much discussion. So far, there is no defined limit value on the basis of which the prot...
    More>>
  • Israel Documents First Case of ‘Florona’, A Combination of COVID-19 and Influenza

    Israel Documents First Case of ‘Florona’, A Combination of COVID-19 and Influenza

    Israel Documents First Case of ‘Florona’, A Combination of COVID-19 and Influenza   Israel has reportedly documented the first case of Florona — a simultaneous infection of COVID-19 and influenza. According to the news website Ynetnews, the double infection was first identi...
    More>>
  • Targeted N vs. S protein in COVID-19 Antibody Testing

    Targeted N vs. S protein in COVID-19 Antibody Testing

    Targeted N vs. S protein in COVID-19 Antibody Testing   Throughout the COVID-19 pandemic, researchers have been working tirelessly to understand the human immune response to SARS-CoV-2, including the duration and level of protection that antibodies may provide against re-infection. Several ...
    More>>
  • This Winter’s Flu Season Epidemic Has Started – What We Know So Far and What Needs To Be Done To Control It

    This Winter’s Flu Season Epidemic Has Started – What We Know So Far and What Needs To Be Done To Control It

    This Winter’s Flu Season Epidemic Has Started – What We Know So Far and What Needs To Be Done To Control It   In the week commencing 13 December the number of flu cases (caused by the influenza virus) detected in the WHO European Region was above what we would normally expect to find i...
    More>>
  • First Omicron Report of A Real World Infection: Highly Contagious with Flu-Like Symptoms

    First Omicron Report of A Real World Infection: Highly Contagious with Flu-Like Symptoms

    First Omicron Report of A Real World Infection: Highly Contagious with Flu-Like Symptoms   The SARS-CoV-2 Omicron variant is setting off a new wave of COVID-19 outbreaks around the world. Epidemiological studies are the basis for revealing the infectivity, immune escape and disease severity ...
    More>>
  • GENESIS products continue to detect SARS-CoV-2 mutant strain Omicron

    GENESIS products continue to detect SARS-CoV-2 mutant strain Omicron

    On 26 November WHO designated B.1.1.529 a variant of concern(VOC) because of preliminary evidence of a detrimental change in COVID-19 epidemiology. As a VOC, it was named Omicron. Omicron has a large number of mutations including more than 30 genetic mutations of the spike protein. Some mutations...
    More>>
  • Use of Antigen-Detection Rapid Diagnostic Testing on COVID-19

    Use of Antigen-Detection Rapid Diagnostic Testing on COVID-19

    Use of Antigen-Detection Rapid Diagnostic Testing on COVID-19   What’s the use of antigen-detection rapid diagnostic testing on COVID-19? WHO recommends that all suspected cases be tested for SARS-CoV-2. Antigen-detection diagnostic testing uses upper respiratory specimen or saliva to test ...
    More>>
  • Genesis COVID-19 IVD TOTAL SOLUTION

    Genesis COVID-19 IVD TOTAL SOLUTION   Globally, as of 4:08pm CET, 9 December 2021, there have been 267,184,623 confirmed cases of COVID-19, including 5,277,327 deaths, reported to WHO. As of 8 December 2021, a total of 8,158,815,265 vaccine doses have been administered. We Genesis launch our...
    More>>
  • MEDICA | GENESIS Attends the Exhibition with Flu&COVID-19 Solutions

    MEDICA | GENESIS Attends the Exhibition with Flu&COVID-19 Solutions   Hangzhou Genesis Biodetection & Biocontrol Co., Ltd. participated in the 53rd MEDICA 2021 World Forum for Medicine in DÜSSELDORF, GERMANY between Nov. 15th-18th. About MEDICA: “MEDICA” was been Founded in 1968, a...
    More>>
  • Respiratory Care Week 2021

    Respiratory Care Week 2021

    The KaiBiLiTM RSV Antigen Rapid Test is an in vitro diagnostic test for the qualitative detection of Respiratory Syncytial Virus (RSV) nucleoprotein antigens in nasopharyngeal (NP) swab and nasal aspirate samples, using the rapid immunochromatographic method. ...
    More>>
  • Meet Genesis in MEDICA,Düsseldorf Germany!

    ●Time: Nov 15-18th, 2021 ●Booth No: 3H14-2   If you would like to get more information about our COVID-19 Total Solution and other reagents, warmly welcome to visit our booth at MEDICA. Genesis is looking forward to meeting you here! If you need support or more information please contact us: Tel...
    More>>
  • KaibiLi COVID-19 Antigen on PEI (Paul-Ehrlich-Institut ) Approval List!

    KaibiLi COVID-19 Antigen get PEI approval KaibiLi COVID-19 Antigen get PEI approval. The BfArM provides a list according to § 1 sentence 1 TestV of the antigen tests for the direct detection of pathogens of the coronavirus SARS-CoV-2, which are intended by the manufacturer for professional use (&...
    More>>